There are differences of opinion when you’re considering treatment for early stage, high-risk prostate cancer. Some facilities believe surgery is the way to go as long as the disease has not spread. Others feel the change in the quality of life has to be balanced against the potential that you’ve improved the overall outcome. “That’s a very serious conversation (patients) should have,” says Dr. Patrick Swift, Clinical Professor of Radiation Oncology at Stanford University Medical Center, “and it involves choosing between surgery or just having radiation with hormone therapy.”
Read More